U.S. markets closed

Analysis of the Emerging Disease Landscape: Novel Coronavirus (COVID-19) - May 2020 - ResearchAndMarkets.com

The "Analysis of the Emerging Disease Landscape - COVID-19 - May 2020" report has been added to ResearchAndMarkets.com's offering.

The epidemiology of COVID-19 is rapidly evolving and a number of companies have begun to invest in this space. The absence of proven therapeutic options and the lack of a vaccine to protect against infection has led to a race to develop effective interventions. A range of players - from pharma and biotech firms to academic institutions and government agencies - have thrown their hats in the ring.

Report Scope

  • Global epidemiology metrics and trends
  • Snapshot of epidemiological trends to date in the top three most-affected countries
  • An overview of the pipeline for antivirals and vaccines
  • Summary of available efficacy data
  • An assessment of the clinical trials landscape by phase, sponsor type, geography, and other key attributes
  • Highlights in deal-making trends, particularly public-private partnerships
  • Spotlight on social media coverage

Reasons to Buy

  • Understand the global epidemiology of COVID-19
  • Obtain a snapshot of epidemiological trends to date in the top three most-affected countries
  • Access an overview of the pipeline for therapeutics and vaccines
  • Stay up to date on available efficacy data for pipeline-stage products
  • View the clinical trials landscape by across key attributes
  • Get up to speed on highlights in deal-making trends, particularly public-private partnerships
  • Monitor top trends in social media coverage

Key Topics Covered

  1. Disease Background
  2. Epidemiology
  3. Pipeline Overview
  4. Clinical Trials
  5. Deal-Making Trends
  6. Social Media Trends
  7. Key Findings
  8. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/7iylis

View source version on businesswire.com: https://www.businesswire.com/news/home/20200701005537/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900